160 related articles for article (PubMed ID: 23432387)
1. Investigation of the effect of probiotic exposure on filaggrin expression in an experimental model of canine atopic dermatitis.
Marsella R; Santoro D; Ahrens K; Thomas AL
Vet Dermatol; 2013 Apr; 24(2):260-e57. PubMed ID: 23432387
[TBL] [Abstract][Full Text] [Related]
2. Does filaggrin expression correlate with severity of clinical signs in dogs with atopic dermatitis?
Marsella R
Vet Dermatol; 2013 Apr; 24(2):266-e59. PubMed ID: 23398596
[TBL] [Abstract][Full Text] [Related]
3. Altered mRNA and protein expression of filaggrin in the skin of a canine animal model for atopic dermatitis.
Santoro D; Marsella R; Ahrens K; Graves TK; Bunick D
Vet Dermatol; 2013 Jun; 24(3):329-36, e73. PubMed ID: 23668858
[TBL] [Abstract][Full Text] [Related]
4. Increased filaggrin-metabolizing enzyme activity in atopic skin: a pilot study using a canine model of atopic dermatitis.
Fanton N; Santoro D; Cornegliani L; Marsella R
Vet Dermatol; 2017 Oct; 28(5):479-e111. PubMed ID: 28393458
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical evaluation of filaggrin polyclonal antibody in atopic and normal beagles.
Marsella R; Samuelson D; Harrington L
Vet Dermatol; 2009 Oct; 20(5-6):547-54. PubMed ID: 20178493
[TBL] [Abstract][Full Text] [Related]
6. Early exposure to probiotics in a canine model of atopic dermatitis has long-term clinical and immunological effects.
Marsella R; Santoro D; Ahrens K
Vet Immunol Immunopathol; 2012 Apr; 146(2):185-9. PubMed ID: 22436376
[TBL] [Abstract][Full Text] [Related]
7. Single blinded, randomized, placebo-controlled study on the effects of ciclosporin on cutaneous barrier function and immunological response in atopic beagles.
White AG; Santoro D; Ahrens K; Marsella R
Vet Immunol Immunopathol; 2018 Mar; 197():93-101. PubMed ID: 29475513
[TBL] [Abstract][Full Text] [Related]
8. Update on canine filaggrin: a review.
Combarros D; Cadiergues MC; Simon M
Vet Q; 2020 Dec; 40(1):162-168. PubMed ID: 32308144
[TBL] [Abstract][Full Text] [Related]
9. Alterations of keratins, involucrin and filaggrin gene expression in canine atopic dermatitis.
Theerawatanasirikul S; Sailasuta A; Thanawongnuwech R; Suriyaphol G
Res Vet Sci; 2012 Dec; 93(3):1287-92. PubMed ID: 22784629
[TBL] [Abstract][Full Text] [Related]
10. Transmission electron microscopy studies in an experimental model of canine atopic dermatitis.
Marsella R; Samuelson D; Doerr K
Vet Dermatol; 2010 Feb; 21(1):81-8. PubMed ID: 20042040
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of caspase-14 in an experimental model of canine atopic dermatitis.
Marsella R; Papastavros V; Ahrens K; Santoro D
Vet J; 2016 Mar; 209():201-3. PubMed ID: 26831171
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Lactobacillus rhamnosus strain GG for the prevention of atopic dermatitis in dogs.
Marsella R
Am J Vet Res; 2009 Jun; 70(6):735-40. PubMed ID: 19496662
[TBL] [Abstract][Full Text] [Related]
13. Cytokine modulation of atopic dermatitis filaggrin skin expression.
Howell MD; Kim BE; Gao P; Grant AV; Boguniewicz M; Debenedetto A; Schneider L; Beck LA; Barnes KC; Leung DY
J Allergy Clin Immunol; 2007 Jul; 120(1):150-5. PubMed ID: 17512043
[TBL] [Abstract][Full Text] [Related]
14. First report in a dog model of atopic dermatitis: expression patterns of protease-activated receptor-2 and thymic stromal lymphopoietin.
Kim HJ; Ahrens K; Park HM; Marsella R
Vet Dermatol; 2015 Jun; 26(3):180-5, e36-7. PubMed ID: 25940870
[TBL] [Abstract][Full Text] [Related]
15. Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.
Marsella R; Olivry T; Carlotti DN;
Vet Dermatol; 2011 Jun; 22(3):239-48. PubMed ID: 21414049
[TBL] [Abstract][Full Text] [Related]
16. Characterization of canine filaggrin: gene structure and protein expression in dog skin.
Kanda S; Sasaki T; Shiohama A; Nishifuji K; Amagai M; Iwasaki T; Kudoh J
Vet Dermatol; 2013 Feb; 24(1):25-31.e7. PubMed ID: 23331676
[TBL] [Abstract][Full Text] [Related]
17. A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic dermatitis.
Naeem AS; Tommasi C; Cole C; Brown SJ; Zhu Y; Way B; Willis Owen SA; Moffatt M; Cookson WO; Harper JI; Di WL; Brown SJ; Reinheckel T; O'Shaughnessy RF
J Allergy Clin Immunol; 2017 Apr; 139(4):1228-1241. PubMed ID: 27913303
[TBL] [Abstract][Full Text] [Related]
18. Filaggrin and atopic march.
Čepelak I; Dodig S; Pavić I
Biochem Med (Zagreb); 2019 Jun; 29(2):020501. PubMed ID: 31223255
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of epidermal tight junction proteins in a dog model of atopic dermatitis.
Kim HJ; Cronin M; Ahrens K; Papastavros V; Santoro D; Marsella R
Vet Dermatol; 2016 Feb; 27(1):40-e11. PubMed ID: 26663564
[TBL] [Abstract][Full Text] [Related]
20. Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect.
Brown SJ; Kroboth K; Sandilands A; Campbell LE; Pohler E; Kezic S; Cordell HJ; McLean WH; Irvine AD
J Invest Dermatol; 2012 Jan; 132(1):98-104. PubMed ID: 22071473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
